The Cancer Center Support Grant (CCSG) is administered by the Koch Institute for Integrative Cancer Research at MIT under the direction of Cynthia Quense, the Assistant Director for Administration. The Koch Institute has a centralized administrative system to support the Members within the Koch Institute building. This structure allows for knowledge and specialization within functional areas while providing administrative staff that are very familiar with the individualized needs of Members and their respective laboratories. The central administrative team (known as the Headquarters Office (HQ)) provides full support in the following key areas: CCSG Administration Processes & Administrative Oversight Koch Institute Leadership, Executive Committee and CCSG / Faculty Meetings Scientific Advisory Board support Koch Institute Membership Processes Faculty Recruitment & Retention ? coordinated with Academic Departments Finance: pre and post award and discretionary fund oversight Pilot Project and Fellowship Award Processes Program and Grant Administration Human Resources (HR) Operations & Space Management (Including renovations, facilities & building maintenance) Reception and Office Management Koch Institute Events and Community activities Coordination and oversight of research administration areas including Environment, Health, and Safety (EHS), Core Facilities and faculty Lab Managers and Administrative Assistants Coordination and linking with MIT Administrative Offices and Academic Departments In addition, the HQ team provides CCSG-specific administrative support to Cancer Center Members outside of the building in the areas of: core facilities operations and billing, membership, program support, funding announcements, Pilot Project and other internal funding processes including cancer-related fellowships. Full administrative support is provided to the entire membership for collaborative grants, including the current U54s; PS-OC and CSBC; as well as donor-sponsored centers and initiatives such as the Marble Center for Cancer Nanomedicine, the Center for Precision Cancer Medicine, the Ludwig Center for Molecular Oncology at MIT and the Stem Cell Initiative.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014051-49
Application #
9937087
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
49
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Lannagan, Tamsin R M; Lee, Young K; Wang, Tongtong et al. (2018) Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut :
Filbin, Mariella G; Tirosh, Itay; Hovestadt, Volker et al. (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331-335
Roper, Jatin; Tammela, Tuomas; Akkad, Adam et al. (2018) Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation. Nat Protoc 13:217-234
Suzuki, Hiroshi I; Spengler, Ryan M; Grigelioniene, Giedre et al. (2018) Deconvolution of seed and RNA-binding protein crosstalk in RNAi-based functional genomics. Nat Genet 50:657-661
McKenney, Anna Sophia; Lau, Allison N; Somasundara, Amritha Varshini Hanasoge et al. (2018) JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. J Clin Invest 128:789-804
Richardson, Christopher E R; Cunden, Lisa S; Butty, Vincent L et al. (2018) A Method for Selective Depletion of Zn(II) Ions from Complex Biological Media and Evaluation of Cellular Consequences of Zn(II) Deficiency. J Am Chem Soc 140:2413-2416
Choudhury, Atish D; Werner, Lillian; Francini, Edoardo et al. (2018) Tumor fraction in cell-free DNA as a biomarker in prostate cancer. JCI Insight 3:
Chen, Pan-Yu; Muzumdar, Mandar Deepak; Dorans, Kimberly Judith et al. (2018) Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells. Cancer Res 78:985-1002
Wong, Madeline Y; Chen, Kenny; Antonopoulos, Aristotelis et al. (2018) XBP1s activation can globally remodel N-glycan structure distribution patterns. Proc Natl Acad Sci U S A 115:E10089-E10098
Viswanathan, Srinivas R; Nogueira, Marina F; Buss, Colin G et al. (2018) Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer. Nat Genet 50:937-943

Showing the most recent 10 out of 904 publications